Your browser doesn't support javascript.
loading
Armstrong strain lymphocytic choriomeningitis virus infection after accidental laboratory exposure.
Caron, Laurence; Delisle, Jean-Sébastien; Strong, James E; Deschambault, Yvon; Lombard-Vadnais, Félix; Labbé, Annie-Claude; Lesage, Sylvie.
Afiliación
  • Caron L; Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, QC, Canada.
  • Delisle JS; Immunologie-oncologie, Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Canada.
  • Strong JE; Immunologie-oncologie, Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Canada.
  • Deschambault Y; Département de médecine, Université de Montréal, Montréal, QC, Canada.
  • Lombard-Vadnais F; National Microbiology Laboratory, Public Health Agency of Canada, 1015 rue Arlington Street, Winnipeg, MB, R3E 3R2, Canada.
  • Labbé AC; Department of Pediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Lesage S; Department of Infectious Diseases and Medical Microbiology, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Virol J ; 20(1): 294, 2023 Dec 12.
Article en En | MEDLINE | ID: mdl-38087355
ABSTRACT

BACKGROUND:

Lymphocytic choriomeningitis virus (LCMV) is a human pathogen naturally present in wild rodents. In addition, LCMV is routinely used in immunology research as a model of viral infection in mice. The Armstrong common laboratory strain and the Clone-13 variant induce acute and chronic infections in mice, respectively. The frequent use of this virus in laboratory settings is associated with a risk of human infection for laboratory personnel. In contrast to LCMV Clone-13, few human laboratory infections with LCMV Armstrong have been reported, leading to a poor understanding of symptoms related to infection with this specific LCMV strain. CASE PRESENTATION A researcher accidentally infected herself percutaneously with LCMV Armstrong. Symptoms including headaches, dizziness, eye pain and nausea appeared seven days post-exposure and lasted ten days. LCMV-IgM antibodies were detected at 28 days post-infection and IgG seroconversion was observed later. Complete recovery was confirmed three months post exposure.

CONCLUSIONS:

Research involving live viruses comes with the risk of infection for research personnel. This case is the first reported accidental human infection with LCMV Armstrong. The symptoms differed from reported infections with LCMV Clone-13, by the absence of fever and vomiting, and presence of leg numbness. This report will therefore help clinicians and public health authorities to recognize the symptoms associated with LCMV Armstrong infections and to offer appropriate counselling to individuals who accidentally expose themselves.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Coriomeningitis Linfocítica / Virus de la Coriomeningitis Linfocítica Límite: Animals / Female / Humans Idioma: En Revista: Virol J Asunto de la revista: VIROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Coriomeningitis Linfocítica / Virus de la Coriomeningitis Linfocítica Límite: Animals / Female / Humans Idioma: En Revista: Virol J Asunto de la revista: VIROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá